These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7530216)

  • 1. A novel member of the TRAF family of putative signal transducing proteins binds to the cytosolic domain of CD40.
    Sato T; Irie S; Reed JC
    FEBS Lett; 1995 Jan; 358(2):113-8. PubMed ID: 7530216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel RING finger protein interacts with the cytoplasmic domain of CD40.
    Hu HM; O'Rourke K; Boguski MS; Dixit VM
    J Biol Chem; 1994 Dec; 269(48):30069-72. PubMed ID: 7527023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of CRAF1, a relative of TRAF, in CD40 signaling.
    Cheng G; Cleary AM; Ye ZS; Hong DI; Lederman S; Baltimore D
    Science; 1995 Mar; 267(5203):1494-8. PubMed ID: 7533327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor.
    Rothe M; Wong SC; Henzel WJ; Goeddel DV
    Cell; 1994 Aug; 78(4):681-92. PubMed ID: 8069916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region.
    Ishida T; Mizushima Si; Azuma S; Kobayashi N; Tojo T; Suzuki K; Aizawa S; Watanabe T; Mosialos G; Kieff E; Yamamoto T; Inoue J
    J Biol Chem; 1996 Nov; 271(46):28745-8. PubMed ID: 8910514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40.
    Rothe M; Sarma V; Dixit VM; Goeddel DV
    Science; 1995 Sep; 269(5229):1424-7. PubMed ID: 7544915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization.
    Pullen SS; Miller HG; Everdeen DS; Dang TT; Crute JJ; Kehry MR
    Biochemistry; 1998 Aug; 37(34):11836-45. PubMed ID: 9718306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. I-TRAF is a novel TRAF-interacting protein that regulates TRAF-mediated signal transduction.
    Rothe M; Xiong J; Shu HB; Williamson K; Goddard A; Goeddel DV
    Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8241-6. PubMed ID: 8710854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling.
    Ishida TK; Tojo T; Aoki T; Kobayashi N; Ohishi T; Watanabe T; Yamamoto T; Inoue J
    Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9437-42. PubMed ID: 8790348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRAF5, an activator of NF-kappaB and putative signal transducer for the lymphotoxin-beta receptor.
    Nakano H; Oshima H; Chung W; Williams-Abbott L; Ware CF; Yagita H; Okumura K
    J Biol Chem; 1996 Jun; 271(25):14661-4. PubMed ID: 8663299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of a new conserved domain in CART1, a novel member of the tumor necrosis factor receptor-associated protein family, which is expressed in breast carcinoma.
    Régnier CH; Tomasetto C; Moog-Lutz C; Chenard MP; Wendling C; Basset P; Rio MC
    J Biol Chem; 1995 Oct; 270(43):25715-21. PubMed ID: 7592751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence, genomic organization, and chromosome localization of the mouse TRADD gene.
    Pan MG; Xiong J; Copeland NG; Gilbert DJ; Jenkins NA; Goeddel DV
    J Inflamm; 1995-1996; 46(3):168-75. PubMed ID: 8844497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a novel tumor necrosis factor-alpha-inducible gene, SCC-S2, containing the consensus sequence of a death effector domain of fas-associated death domain-like interleukin- 1beta-converting enzyme-inhibitory protein.
    Kumar D; Whiteside TL; Kasid U
    J Biol Chem; 2000 Jan; 275(4):2973-8. PubMed ID: 10644768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-affinity interactions of tumor necrosis factor receptor-associated factors (TRAFs) and CD40 require TRAF trimerization and CD40 multimerization.
    Pullen SS; Labadia ME; Ingraham RH; McWhirter SM; Everdeen DS; Alber T; Crute JJ; Kehry MR
    Biochemistry; 1999 Aug; 38(31):10168-77. PubMed ID: 10433725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two differently regulated nuclear factor kappaB activation pathways triggered by the cytoplasmic tail of CD40.
    Tsukamoto N; Kobayashi N; Azuma S; Yamamoto T; Inoue J
    Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1234-9. PubMed ID: 9990007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TANK, a co-inducer with TRAF2 of TNF- and CD 40L-mediated NF-kappaB activation.
    Cheng G; Baltimore D
    Genes Dev; 1996 Apr; 10(8):963-73. PubMed ID: 8608943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity.
    Hollenbaugh D; Grosmaire LS; Kullas CD; Chalupny NJ; Braesch-Andersen S; Noelle RJ; Stamenkovic I; Ledbetter JA; Aruffo A
    EMBO J; 1992 Dec; 11(12):4313-21. PubMed ID: 1385114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD40-mediated signaling in monocytic cells: up-regulation of tumor necrosis factor receptor-associated factor mRNAs and activation of mitogen-activated protein kinase signaling pathways.
    Pearson LL; Castle BE; Kehry MR
    Int Immunol; 2001 Mar; 13(3):273-83. PubMed ID: 11222496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis for CD40 signaling mediated by TRAF3.
    Ni CZ; Welsh K; Leo E; Chiou CK; Wu H; Reed JC; Ely KR
    Proc Natl Acad Sci U S A; 2000 Sep; 97(19):10395-9. PubMed ID: 10984535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRAF-interacting protein (TRIP): a novel component of the tumor necrosis factor receptor (TNFR)- and CD30-TRAF signaling complexes that inhibits TRAF2-mediated NF-kappaB activation.
    Lee SY; Lee SY; Choi Y
    J Exp Med; 1997 Apr; 185(7):1275-85. PubMed ID: 9104814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.